Table 2.
Liposome formulation* |
Effective diameter in nm (PDI)† |
Zeta Potential (mV) |
|
---|---|---|---|
Rhodamine liposomes for in vitro optical imaging |
Non-PEG – 100 | 108 (0.074) | − 81 ± 7 |
Non-PEG – 200 | 166 (0.059) | − 65 ± 2 | |
Non-PEG – 400 | 270 (0.177) | − 70 ± 4 | |
PEG – 100 | 103 (0.073) | − 36 ± 2 | |
PEG – 200 | 146 (0.111) | − 39 ± 2 | |
PEG – 400 | 218 (0.125) | − 39 ± 3 | |
Liposomal-iodixanol for in vitro CT imaging |
Non-PEG- 100 | 93 (0.067) | − 58 ± 3 |
Non-PEG – 200 | 144 (0.115) | − 60 ± 2 | |
Non-PEG – 400 | 225 (0.121) | − 69 ± 2 | |
PEG – 100 | 98 (0.112) | − 37 ± 2 | |
PEG – 200 | 119 (0.108) | − 33 ± 2 | |
PEG – 400 | 153 (0.071) | − 33 ± 1 | |
Liposomal-iodixanol for in vivo studies |
IV-400 | 172 (0.1) | − 69 ± 1 |
the numbers 100, 200 and 400 indicate pore sizes of filter membranes through which the liposomes were extruded.
PDI is the poly-dispersity index of the particle sizes, defined as the ratio of the volume mean diameter to the number mean diameter.